Tirzepatide taken for weight loss may lead to Colonic Ischemia: Case report Dr.Niharika Harsha B23 Dec 2024 9:15 AM ISTA recent case published in the journal ACG CASE REPORTS JOURNAL found a possible risk of colonic ischemia caused by the usage of tirzepatide for...
USFDA approves Eli Lilly weight loss treatment Zepbound for obstructive sleep apnea Ruchika Sharma21 Dec 2024 1:30 PM ISTstyle="text-align: justify; ">Indianapolis: Eli Lilly and Company has announced the U.S. Food and Drug Administration (FDA) has...
Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen Susmita Roy17 Dec 2024 6:00 PM ISTNew Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the...
Tirzepatide versus Semaglutide- Surmount-5 trial reveals head-on comparison results Dr. Prem Aggarwal5 Dec 2024 12:00 PM ISTUS: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company announced that participants...
24 year old starts weight loss journey with Tirzepatide, suffers acute liver Injury: Case report Medha Baranwal28 Nov 2024 12:45 PM ISTKuwait: A case study published in the European Journal of Case Reports in Internal Medicine highlights the importance of healthcare practitioners...
Tirzepatide can reduce mortality risk among heart failure with preserved heart function and obesity: Study Dr. Kamal Kant Kohli22 Nov 2024 10:00 PM ISTWeight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart...
Tirzepatide Demonstrates Long-Term Weight Reduction and Diabetes Risk Reduction in Obesity and Prediabetes: NEJM Medha Baranwal15 Nov 2024 9:00 AM ISTUSA: In recent years, medical advancements have provided new hope for the management of obesity and the prevention of type 2 diabetes, with...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
Real-World Analysis of Tirzepatide Reveals Comparable Safety Profile to GLP-1 Receptor Agonists Medha Baranwal20 Sept 2024 9:30 AM ISTItaly: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety profile of tirzepatide...
Semaglutide and tirzepatide lead to better blood sugar control and weight loss in individuals with type 1 diabetes, finds study Dr. Kamal Kant Kohli16 Sept 2024 8:45 AM ISTSemaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who...
Tirzepatide effects greater weight loss among women compared to men, claims study Dr. Kamal Kant Kohli13 Sept 2024 8:00 AM ISTAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...
Tirzepatide may significantly delay diabetes progression among adults with pre-diabetes and obesity: Study Dr. Kamal Kant Kohli23 Aug 2024 9:00 AM ISTTirzepatide may reduce risk of developing type 2 diabetes by 94% among adult patients with pre-diabetes and obesity finds a phase lll study over a...
